CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 40 enrolled
Drug / intervention
zonisamide +1 moredrug
Likely dose
zonisamide 500mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00595556
NCT00595556Phase 4Completed
CompareCT.gov

Zonisamide vs. Placebo in the Treatment of Alcohol Dependence

UConn Health·interventional·Posted Jan 16, 2008·Updated Oct 15, 2010

In Brief

A Phase 4 clinical trial evaluating zonisamide and Placebo for Alcoholism and 2 related conditions. Completed, enrolled 40 participants across 1 site.

Detailed Summary

This is a pilot study designed to examine the potential efficacy and tolerability of zonisamide compared to placebo for the treatment of alcohol dependence.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcoholism, Alcohol Abuse, Alcohol Dependence
CountriesUnited States
CollaboratorsNational Institute on Alcohol Abuse and Alcoholism (NIAAA), National Center for Research Resources (NCRR)

Timeline

Phase 4CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 16, 2008
Enrollment StartJul 1, 2006
Primary CompletionMay 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 18.5 years ago

Interventions

zonisamidedrug

flexible dosages of 100-500mg/day

Placebodrug

Placebo